Steven Targum - Alterity Therapeutics Chief Advisor
| ATHE Stock | USD 3.72 0.27 6.77% |
Insider
Steven Targum is Chief Advisor of Alterity Therapeutics
| Phone | 61 3 9349 4906 |
| Web | https://alteritytherapeutics.com |
Alterity Therapeutics Management Efficiency
The company has return on total asset (ROA) of (0.5266) % which means that it has lost $0.5266 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0447) %, meaning that it created substantial loss on money invested by shareholders. Alterity Therapeutics' management efficiency ratios could be used to measure how well Alterity Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Leila MD | Pmv Pharmaceuticals | 61 | |
| Arnold Levine | Pmv Pharmaceuticals | 85 | |
| Joseph Zakrzewski | AN2 Therapeutics | 63 | |
| Scott Anderson | Anebulo Pharmaceuticals | N/A | |
| David Mack | Pmv Pharmaceuticals | 63 | |
| Gregory MBA | Artelo Biosciences | 62 | |
| Roeland Nusse | Surrozen | 75 | |
| Rex CFA | Anebulo Pharmaceuticals | 64 | |
| Qiyong Liu | Transcode Therapeutics | 60 | |
| Sanjay Chanda | AN2 Therapeutics | 60 | |
| MBA BS | AN2 Therapeutics | 49 | |
| Robert Dudley | Transcode Therapeutics | 73 | |
| Rowena Albanna | Aditxt Inc | 59 | |
| Deepika PharmD | Pmv Pharmaceuticals | 49 | |
| Denise Carter | Quoin Pharmaceuticals Ltd | 56 | |
| Peter Rhode | HCW Biologics | 67 | |
| Laxminarayan Bhat | Reviva Pharmaceuticals Holdings | 60 | |
| Wang Xu | NovaBay Pharmaceuticals | 36 | |
| Justin Esq | NovaBay Pharmaceuticals | 47 | |
| MBA MBA | Adial Pharmaceuticals | 47 | |
| Jack Reich | Adial Pharmaceuticals | 75 | |
Management Performance
| Return On Equity | -1.04 | ||||
| Return On Asset | -0.53 |
Alterity Therapeutics Leadership Team
Elected by the shareholders, the Alterity Therapeutics' board of directors comprises two types of representatives: Alterity Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alterity. The board's role is to monitor Alterity Therapeutics' management team and ensure that shareholders' interests are well served. Alterity Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alterity Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Cherny, Head Research | ||
| BBus CA, Company Sec | ||
| BSc BSc, CoFounder Chairman | ||
| Kathryn Andrews, Chief Officer | ||
| Steven Targum, Chief Advisor | ||
| CPA BCom, Chief Officer | ||
| Steven MD, Chief Advisor | ||
| BCom BSc, Chief Officer | ||
| Geoffrey BSc, CoFounder Chairman | ||
| David MD, Chief Officer | ||
| Rudolph Tanzi, Chief Board |
Alterity Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Alterity Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.04 | ||||
| Return On Asset | -0.53 | ||||
| Operating Margin | (6.13) % | ||||
| Current Valuation | 24.77 M | ||||
| Shares Outstanding | 8.74 M | ||||
| Shares Owned By Institutions | 1.28 % | ||||
| Number Of Shares Shorted | 148.54 K | ||||
| Price To Earning | (4.84) X | ||||
| Price To Book | 4.36 X | ||||
| Price To Sales | 8.68 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alterity Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade Alterity Stock refer to our How to Trade Alterity Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alterity Therapeutics. If investors know Alterity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alterity Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alterity Therapeutics is measured differently than its book value, which is the value of Alterity that is recorded on the company's balance sheet. Investors also form their own opinion of Alterity Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Alterity Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alterity Therapeutics' market value can be influenced by many factors that don't directly affect Alterity Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alterity Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alterity Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alterity Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.